Newell Brands To Cut Jobs

Newell Brands, Inc. (NWL), a distributor of consumer and commercial products, said on Monday that it is axing around 13 percent of its office positions to cut costs. It will also record charges by end of this year.

Ravi Saligram, CEO of Newell, said: "Specifically, we are evolving our operating model into three operating segments based on similarities of consumer and customer dynamics, which will reduce duplication and yield synergies."

Newell is consolidating its five operating segments into three operating segments.

The company will combine its previously reported Commercial Solutions, Home Appliances, and Home Solutions segments into one operating segment- Home & Commercial Solutions.

Learning & Development and Outdoor & Recreation will remain as its other two operating segments.

The company will start slashing the headcount in the first quarter, which is expected to be completed by the end of this year.

In connection with the cost cutting program, Newell expects to realize annualized pre-tax savings of $220 to $250 million.

These restructuring charges are projected to be in the range of $100 million to $130 million, and are anticipated to be substantially incurred by the end of 2023.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT